Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 1 (2004), Issue 3 (December)

1. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.
   Am J Gastroenterol, 99(12): 2385-92. [Abstract] [Full-text]
2. Genetic risk factors for infection in patients with early rheumatoid arthritis.
   Genes Immun, 5(8): 641-7. [Abstract] [Full-text]
3. DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets.
   Genes Immun, 5(8): 597-608. [Abstract] [Full-text]
4. B lymphocyte depletion in rheumatoid arthritis: targeting of CD20.
   Curr Dir Autoimmun, 8: 175-92. [Abstract] [Full-text]
5. TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
   J Clin Invest, 114(11): 1603-11. [Abstract] [Full-text]
6. Illness-specific and general perceptions of social relationships in adjustment to rheumatoid arthritis: the role of interpersonal expectations.
   Ann Behav Med, 28(3): 203-10. [Abstract] [Full-text]
7. Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study.
   J Pediatr, 145(6): 856-7. [Abstract] [Full-text]
8. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment.
   Blood, 104(13): 4029-37. [Abstract] [Full-text]
9. New cyclooxygenase-2 inhibitor DFU regulates vascular endothelial growth factor expression in rheumatoid synoviocytes.
   Immunol Lett, 96(2): 219-24. [Abstract] [Full-text]
10. Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis.
    Scand J Immunol, 60(6): 625-30. [Abstract] [Full-text]
11. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
    Scand J Immunol, 60(6): 552-65. [Abstract] [Full-text]
12. Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis.
    Proc Natl Acad Sci U S A, 101(49): 17180-5. [Abstract] [Full-text]
13. Plasma TNF binding capacity in patients with juvenile idiopathic arthritis.
    Int Immunopharmacol, 5(1): 73-7. [Abstract] [Full-text]
14. Does melatonin play a disease-promoting role in rheumatoid arthritis?
    J Neuroimmunol, 158(1): 106-11. [Abstract] [Full-text]
15. The role of biologicals in early rheumatoid arthritis.
    Best Pract Res Clin Rheumatol, 19(1): 179-89. [Abstract] [Full-text]
16. Therapeutic strategies in early rheumatoid arthritis.
    Best Pract Res Clin Rheumatol, 19(1): 163-77. [Abstract] [Full-text]
17. What are the goals and principles of management in the early treatment of rheumatoid arthritis?
    Best Pract Res Clin Rheumatol, 19(1): 147-61. [Abstract] [Full-text]
18. How to predict prognosis in early rheumatoid arthritis.
    Best Pract Res Clin Rheumatol, 19(1): 137-46. [Abstract] [Full-text]
19. What are the consequences of early rheumatoid arthritis for the individual?
    Best Pract Res Clin Rheumatol, 19(1): 117-36. [Abstract] [Full-text]
20. Imaging in early rheumatoid arthritis: roles of magnetic resonance imaging, ultrasonography, conventional radiography and computed tomography.
    Best Pract Res Clin Rheumatol, 19(1): 91-116. [Abstract] [Full-text]
21. How to assess early rheumatoid arthritis in daily clinical practice.
    Best Pract Res Clin Rheumatol, 19(1): 73-89. [Abstract] [Full-text]
22. Early diagnosis of rheumatoid arthritis.
    Best Pract Res Clin Rheumatol, 19(1): 55-72. [Abstract] [Full-text]
23. Does early rheumatoid arthritis exist?
    Best Pract Res Clin Rheumatol, 19(1): 37-53. [Abstract] [Full-text]
24. The different stages of synovitis: acute vs chronic, early vs late and non-erosive vs erosive.
    Best Pract Res Clin Rheumatol, 19(1): 19-35. [Abstract] [Full-text]
25. Are early arthritis clinics necessary?
    Best Pract Res Clin Rheumatol, 19(1): 1-17. [Abstract] [Full-text]
26. Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.
    Cytokine, 28(4): 158-61. [Abstract] [Full-text]
27. Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis.
    J Med Chem, 47(26): 6435-8. [Abstract] [Full-text]
28. Survival of Bi-Metric femoral stems in 77 total hip arthroplasties for juvenile chronic arthritis.
    Int Orthop, 28(6): 357-61. [Abstract] [Full-text]
29. Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity.
    Clin Exp Med, 4(3): 148-51. [Abstract] [Full-text]
30. Multiple sialolithiasis in the parotid gland with Sjögren's syndrome and its sonographic findings--report of 3 cases.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 99(1): 85-92. [Abstract] [Full-text]
31. Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands.
    Arthritis Rheum, 51(6): 964-73. [Abstract] [Full-text]
32. Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis.
    Arthritis Rheum, 51(6): 899-908. [Abstract] [Full-text]
33. Effect of glucocorticoids on the arteries in rheumatoid arthritis.
    Arthritis Rheum, 50(12): 3813-22. [Abstract] [Full-text]
34. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis.
    Arthritis Rheum, 50(12): 3792-803. [Abstract] [Full-text]
35. A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis.
    Arthritis Rheum, 50(12): 3878-87. [Abstract] [Full-text]
36. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis.
    Arthritis Rheum, 50(12): 3783-91. [Abstract] [Full-text]
37. Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody.
    Arthritis Rheum, 50(12): 3776-82. [Abstract] [Full-text]
38. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients.
    Arthritis Rheum, 50(12): 3866-77. [Abstract] [Full-text]
39. Familial aggregation of juvenile idiopathic arthritis.
    Arthritis Rheum, 50(12): 4022-7. [Abstract] [Full-text]
40. Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma.
    Arthritis Rheum, 50(12): 3856-65. [Abstract] [Full-text]
41. Evidence for a novel rheumatoid arthritis susceptibility locus on chromosome 6p.
    Arthritis Rheum, 50(12): 3823-30. [Abstract] [Full-text]
42. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
    Arthritis Rheum, 50(12): 3974-84. [Abstract] [Full-text]
43. Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjogren's syndrome.
    Arthritis Rheum, 50(12): 3968-73. [Abstract] [Full-text]
44. NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis.
    Arthritis Rheum, 50(12): 3844-55. [Abstract] [Full-text]
45. Enhanced generation of endothelial cells from CD34+ cells of the bone marrow in rheumatoid arthritis: possible role in synovial neovascularization.
    Arthritis Rheum, 50(12): 3888-96. [Abstract] [Full-text]
46. Managing arthritis and employment: making arthritis-related work changes as a means of adaptation.
    Arthritis Rheum, 51(6): 909-16. [Abstract] [Full-text]
47. Mental health status and leisure-time physical activity contribute to fatigue intensity in patients with spondylarthropathy.
    Arthritis Rheum, 51(6): 1004-8. [Abstract] [Full-text]
48. Physical self perceptions of women with rheumatoid arthritis.
    Arthritis Rheum, 51(6): 958-63. [Abstract] [Full-text]
49. Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis.
    Arthritis Rheum, 51(6): 952-7. [Abstract] [Full-text]
50. Silver ring splints improve dexterity in patients with rheumatoid arthritis.
    Arthritis Rheum, 51(6): 947-51. [Abstract] [Full-text]
51. Discordant expression of HLA class II-associated co-chaperones and HLA-DRB alleles in cultured fibroblast-like synoviocytes.
    Hum Immunol, 65(12): 1516-29. [Abstract] [Full-text]
52. HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B*2707.
    Hum Immunol, 65(12): 1451-4. [Abstract] [Full-text]
53. Relationship between the tumor necrosis factor receptor II (TNF-RII) gene polymorphism and sTNF-RII plasma levels in healthy controls and in rheumatoid arthritis.
    Hum Immunol, 65(12): 1420-6. [Abstract] [Full-text]
54. Lupus erythematosus with leflunomide: induction or reactivation?
    Ann Rheum Dis, 64(1): 153-5. [Abstract] [Full-text]
55. Circulating leptin levels in juvenile idiopathic arthritis: a marker of nutritional status?
    Ann Rheum Dis, 64(1): 149-52. [Abstract] [Full-text]
56. Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate.
    Ann Rheum Dis, 64(1): 141-3. [Abstract] [Full-text]
57. Teleradiotherapy of joints in rheumatoid arthritis: lack of efficacy.
    Ann Rheum Dis, 64(1): 138-40. [Abstract] [Full-text]
58. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study.
    Ann Rheum Dis, 64(1): 130-3. [Abstract] [Full-text]
59. Six months open label trial of leflunomide in active ankylosing spondylitis.
    Ann Rheum Dis, 64(1): 124-6. [Abstract] [Full-text]
60. Capability for daily activities in old people with rheumatoid arthritis: a population based study.
    Ann Rheum Dis, 64(1): 56-8. [Abstract] [Full-text]
61. Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium.
    Ann Rheum Dis, 64(1): 13-20. [Abstract] [Full-text]
62. MR imaging features of foot involvement in ankylosing spondylitis.
    Eur J Radiol, 53(1): 110-9. [Abstract] [Full-text]
63. Is rheumatoid arthritis disappearing?
    Ann Rheum Dis, 64(1): 7-10. [Abstract] [Full-text]
64. Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis.
    Ann Rheum Dis, 64(1): 52-5. [Abstract] [Full-text]
65. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Ann Rheum Dis, 64(1): 44-51. [Abstract] [Full-text]
66. A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.
    Ann Rheum Dis, 64(1): 64-9. [Abstract] [Full-text]
67. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
    Ann Rheum Dis, 64(1): 114-7. [Abstract] [Full-text]
68. Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis.
    Ann Rheum Dis, 64(1): 59-63. [Abstract] [Full-text]
69. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.
    Ann Rheum Dis, 64(1): 38-43. [Abstract] [Full-text]
70. Estimated prediagnosis radiological progression: an important tool for studying the effects of early disease modifying antirheumatic drug treatment in rheumatoid arthritis.
    Ann Rheum Dis, 64(1): 134-7. [Abstract] [Full-text]
71. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system.
    Ann Rheum Dis, 64(1): 127-9. [Abstract] [Full-text]
72. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia.
    J Oral Pathol Med, 34(1): 1-6. [Abstract] [Full-text]
73. Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis.
    Intern Med J, 34(12): 687-93. [Abstract] [Full-text]
74. Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity.
    Rheumatology (Oxford), 44(1): 55-60. [Abstract] [Full-text]
75. Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis.
    Rheumatology (Oxford), 44(1): 51-4. [Abstract] [Full-text]
76. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
    Rheumatology (Oxford), 44(1): 40-50. [Abstract] [Full-text]
77. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis.
    Rheumatology (Oxford), 44(1): 120-5. [Abstract] [Full-text]
78. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.
    Rheumatology (Oxford), 44(1): 74-9. [Abstract] [Full-text]
79. Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients.
    Rheumatology (Oxford), 44(1): 105-10. [Abstract] [Full-text]
80. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
    Rheumatology (Oxford), 44(1): 89-94. [Abstract] [Full-text]
81. Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis.
    Rheumatology (Oxford), 44(1): 32-9. [Abstract] [Full-text]
82. Parent-child interactions among children with juvenile fibromyalgia, arthritis, and healthy controls.
    Pain, 113(1): 201-10. [Abstract] [Full-text]
83. Avanta versus Swanson silicone implants in the MCP joint--a prospective, randomized comparison of 30 patients followed for 2 years.
    J Hand Surg [Br], 30(1): 8-13. [Abstract] [Full-text]
84. A comparative study of outcome between the Neuflex and Swanson metacarpophalangeal joint replacements.
    J Hand Surg [Br], 30(1): 3-7. [Abstract] [Full-text]
85. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.
    Invest Ophthalmol Vis Sci, 46(1): 46-50. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.